高效液相色谱-串联质谱法测定水产品中红霉素的残留

研究了水产品中红霉素残留量测定的新方法. 该方法以红霉素同位素标记物(Erythromycin, N, N-Dimethyl-13C2)为内标物, 样品用乙腈提取、正己烷净化. 分析条件为: 以Hypersil C18为色谱分离柱, 甲醇和0.1 mmol/L 乙酸为流动相, 用带有电喷雾离子源的三重四极杆串联质谱测定, 内标法定量. 红霉素在添加量0.5～20.0 μg/kg的范围内, 回收率为87.0%～97.8%, 相对标准偏差小于10%, 方法检出限为0.5 μg/kg.     

高效液相色谱-串联质谱法测定肠衣中17种磺胺类药物残留量

建立了一种以13C6-磺胺二甲基嘧啶为内标快速测定肠衣中17种磺胺类药物残留量的方法.样品经过V(乙腈)∶V(乙酸乙酯)=1∶1 混合溶剂提取后,离心,上清液在旋转蒸发仪上蒸发至干,体积分数30%甲醇溶液定容,正己烷除去脂肪,经过滤膜后,进高效液相色谱-串联四极杆质谱进行分析,内标法定量.方法的回收率在80%～100%之间,相对标准偏差在15.4%以下,定量限为1.0 μg/kg(磺胺脒为2.0 μg/kg),检出限在0.4 μg/kg以下(磺胺脒为1.0 μg/kg).方法适合于大批量样品的快速检测.     

蔬菜中26种农药残留的高效液相色谱-串联质谱法测定

建立了蔬菜中26种农药的反相高效液相色谱-电喷雾串联质谱 (LC-ESI MS/MS) 检测方法.蔬菜样品经含0.1%醋酸的乙腈提取、浓缩、分散型固相萃取净化,液相色谱串联质谱测定,内标法定量.26种农药在5.0 ～200 μg/L范围内线性关系良好(r2＞0.997).在豌豆、菠菜、脱水葱3种基质中的检出限和定量下限均为2.0 μg/kg和5.0 μg/kg.在5.0、10.0、40.0 μg/kg 3个添加水平下,26种农药的回收率为70% ～110%,精密度(RSD)小于15%.方法准确、灵敏、简单,适用于蔬菜中26种农药残留的同时测定.     

高效液相色谱-串联质谱联用测定蜂王浆中的三种硝基咪唑类残留

建立了高效液相色谱-串联质谱联用测定蜂王浆中甲硝唑(MTZ)、二甲硝唑(DMZ)和洛硝哒唑3(RNZ)种硝基咪唑类残 留的方法。使用氢氧化钠溶液溶解样品后,以乙酸乙酯液液萃取提取蜂王浆样品中的硝基咪唑类残留物。该法简便快捷, 适合大批量样品处理。采用氘代二甲硝唑作为内标和利用高选择性反应监测(H-RSM)技术,降低了基质干扰,增加了定量的 准确性。实验结果表明DMZ检测下限可以达到1.0 μg/kg,MTZ和RNZ检测下限可以达到0.5 μg/kg（S/N大于5）;DMZ 定量下限可以达到2.0 μg/kg,MTZ和RNZ定量下限可以达到1.0 μg/kg（S/N大于10）。线性范围为2.0～200 μg/L, 添加回收率为96.6%~110.6%(内标校正),相对标准偏差（RSD）为2.1%~7.4%。     

高效液相色谱-质谱/质谱法测定蛋黄粉中硝基呋喃代谢产物

采用固相基质分散技术, 液-液分配净化, 同位素内标定量, 建立了蛋黄粉中呋喃它酮、呋喃西林、呋喃妥因和呋喃唑酮等硝基呋喃类药物代谢产物残留的高效液相色谱-质谱/质谱测定方法. 方法测定低限为0.5 μg/kg;线性范围为0.5～6.0 μg/kg;室内验证回收率范围为90.06%～109.8%;相对标准偏差2.0%～7.7%. 该方法适用于残留检测实验室对蛋黄粉类基质中硝基呋喃代谢产物的监控检测.     

加速溶剂萃取气相色谱质谱法测定污泥、底泥及土壤样品中的合成麝香

建立了污泥、底泥及土壤样品中7种合成麝香的分析方法.采用加速溶剂萃取(ASE)提取,经硅胶/中性氧化铝复合层析柱净化后,浓缩并定容洗脱液,用GC-SIM-MS进行检测.本方法对替代物标样荧蒽-d10的回收率为89.7%～110.9%.以六氯苯-c13为内标,7种合成麝香的线性范围为0.6～100.0 μg/kg.底泥和土壤中麝香的检出限为0.25～0.33 μg/kg(S/N=3); 污泥中的检出限为2.9～3.3 μg/kg(S/N=3).基质加标回收实验的平均回收率为83.6%～105.1%; RSD为3.2%～9.8%.本方法准确、快速,可用于实际样品的检测.     

气相色谱-质谱法测定氟涂料中全氟辛酸及其盐类物质

超声萃取技术萃取氟涂料中的全氟辛酸及其盐类物质,萃取液经固相萃取、浓缩后与乙酰化试剂反应,以全氟癸酸甲酯为内标物内标法进行定量测定.对气相色谱-质谱条件进行选择,方法的线性范围为1.0～1×105μg·L-1,相关系数为0.9997,检出限为0.1μg·L-1,在高低两种浓度水平(100 μg·L-1及1000 μg·L-1 PFOA)进行精密度和回收率试验,所得相对标准偏差分别为4.24%和3.58%,回收率在86%～111%之间.     

高效液相色谱-串联质谱法测定猪肉中泰拉霉素残留

建立了高效液相色谱-串联质谱(HPLC-MS/MS)测定猪肉样品中新型兽药泰拉霉素残留的方法.样品用V(甲醇): V(0.1% H3PO4)=70: 30混合溶液提取,经离心后用PCX固相萃取小柱净化, 以SymmetryC8色谱柱为分离柱,在串联质谱多反应监测(MRM)模式下检测,内标法定量.方法的线性范围为10～500 μg/kg,检出限为5.0 μg/kg,在3个浓度水平(10,20和50 μg/kg)进行添加实验,平均回收率为93.1%～105.5%; 批内相对标准偏差为1.5%～4.6%; 批间相对标准偏差为1.8 %～5.6%.     

气相色谱-负离子化学电离质谱法分析深海鱼油 食品中的五种多溴联苯醚残留

建立了气相色谱-负离子化学电离质谱法(GC-NCI/MS)同时分析深海鱼油食品中5种多溴联苯醚残留的分析方法。深海鱼油食品用正己烷超声提取、中性与酸性硅胶色谱柱净化和正己烷洗脱后,以PCB103为内标物,采用GC-NCI/MS的选择离子监测方式(SIM)分析;同时探讨了5种多溴联苯醚的NCI/MS特征离子的断裂机理。当空白深海鱼油食品的加标浓度为20.0和100.0 μg/kg时,加标回收率为88.6%～111.3%,相对标准偏差为3.8%～13.5%,方法的检测限为0.77～1.34 μg/kg,线性范围为1.0～500.0 μg/kg,相关系数均大于0.9992。此方法已成功地应用于深海鱼油食品中5种痕量多溴联苯醚残留的同时分析。     

同位素稀释液相色谱-串联质谱法测定化妆品中的N-亚硝基二乙醇胺

建立了化妆品中N-亚硝基二乙醇胺(NDELA)的同位素稀释液相色谱-串联质谱分析方法。水溶性化妆品样品以水为提取溶剂提取,样品提取液经高速离心处理后,上清液过Oasis HLB固相萃取柱净化。脂溶性化妆品样品用二氯甲烷和水混合溶剂进行液-液分配萃取。NDELA经Waters Atlantis T3色谱柱(150 mm×2.1 mm,3 μm)分离后在多反应监测模式下进行串联质谱定性及定量分析,以d8-NDELA为内标定量。NDELA的方法定量限为50 μg/kg;在50-250 μg/kg的3个添加水平范围内的平均回收率为89.1%～98.2%,日内精密度均小于9%,日间精密度均小于11%。该方法能够满足化妆品中NDELA的检测要求。     

Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma

A simple, rapid, sensitive and specific liquid chromatography/electrospray ionization mass spectrometry method was developed and validated to quantify azithromycin in human plasma, using erythromycin as the internal standard (IS). A simple sample preparation method of protein precipitation with methanol was employed. Methanol, acetonitrile and water (12:30:58, v/v/v) were used as the isocratic mobile phase, with 0.1% formic acid and 0.1% ammonium acetate in water. Selected ion monitoring was specific for azithromycin and erythromycin. The assay was linear over the concentration range 4.69-600 ng/mL. The correlation coefficients for the calibration curves ranged from 0.9994 to 0.9998. The intra- and inter-day precisions, calculated from quality control samples, were less than 8.24%. The method was employed in a pharmacokinetic study after oral administration of 500 mg azithromycin dispersible tablet to 20 healthy volunteers.     

Determination of erythromycin base and 2'-acetylerythromycin in human plasma using high-performance liquid chromatography with electrochemical detection

A high-performance liquid chromatographic method for the determination of plasma concentrations of erythromycin base and 2'-acetylerythromycin, an ester prodrug of erythromycin, is described. tert.-Butyl methyl ether extracts of 1-ml plasma samples (pH 10) were chromatographed on a C18 reversed-phase column. A three-electrode coulometric detector (oxidation potentials +0.65 and +0.85 V) was used for quantitation. Oleandomycin was used as an internal standard. The method has good precision and accuracy, is linear in the range 0.25-7.5 mg/l and has proved to be suitable for pharmacokinetic studies in humans. Correlation with a microbiological assay was satisfactory (r greater than or equal to 0.95), but the chromatographic method gave ca. 30% higher values.     

Matrix effect in high‐performance liquid chromatography‐tandem mass spectrometry analysis of antibiotics in environmental water samples

This paper describes the matrix effect during the analysis of ten antibiotic compounds in water by SPE followed by HPLC‐ESI‐MS/MS. The target analytes were tetracycline, oxytetracycline (tetracyclines), sulfathiazole, sulfamethazine, sulfadiazine (sulfonamides), erythromycin‐H₂O, roxithromycine, spiramycin (macrolides), ofloxacin, and norfloxacin (quinolones). The matrix effect was examined for internal standards and the target analytes in five different water matrixes, with signal suppression being increased in the order: ultrapure water, tap water, river water, sewage effluent, and sewage influent. A combined application of the internal standards and matrix‐matched extract calibration was shown to be successful in compensating the matrix effect for the analytes. The procedural recovery of the target compounds in sewage effluents and influents was higher than in river water samples, which was further enhanced by sample acidification to pH 2. The validity of the internal standard based matrix‐matched calibration approach was verified by the standard addition method.     

Validation of erythromycin microbiological assay using an alternative experimental design

The agar diffusion method, widely used in antibiotic dosage, relates the diameter of the inhibition zone to the dose of the substance assayed. An experimental plan is proposed that may provide better results and an indication of the assay validity. The symmetric or balanced assays (2 x 2) as well as those with interpolation in standard curve (5 x 1) are the main designs used in the dosage of antibiotics. This study proposes an alternative experimental design for erythromycin microbiological assay with the evaluation of the validation parameters of the method referring to linearity, precision, and accuracy. The design proposed (3 x 1) uses 3 doses of standard and 1 dose of sample applied in a unique plate, aggregating the characteristics of the 2 x 2 and 5 x 1 assays. The method was validated for erythromycin microbiological assay through agar diffusion, revealing its adequacy to linearity, precision, and accuracy standards. Likewise, the statistical methods used demonstrated their accordance with the method concerning the parameters evaluated. The 3 x 1 design proved to be adequate for the dosage of erythromycin and thus a good alternative for erythromycin assay.     

红霉素与水杨基荧光酮胶束增敏荷移反应光度分析

本文提出了一种基于胶束增敏荷移反应测定红霉素的光度分析法.研究了在阴离子表面活性剂十二烷基硫酸钠(SDS)胶束体系中红霉素作为电荷供体与电荷受体水杨基荧光酮(SAF)之间的荷移络合物的光谱性质.发现SDS对该体系有增敏作用(ε=3.95×104 L·mol-1·cm-1提高近3倍),红霉素浓度在0.73mg/L～51.4mg/L范围内符合比尔定律,r=0.9999.本方法用于片剂中红霉素含量的测定,回收率为99.7%,9次测定的相对标准偏差为0.24%.     

Confirmatory method for macrolide residues in bovine tissues by micro-liquid chromatography-tandem mass spectrometry

A new confirmatory method for three macrolides (tylosin, tilmicosin and erythromycin) in bovine muscle, liver and kidney by micro-LC-MS-MS using an atmospheric pressure ionisation source and an ionspray interface has been developed. Roxithromycin was used as internal standard. The molecular related ions, [M+2H]2+, at m/z 435 for tilmicosin, and [M+H]+, at m/z 734 and 916 for erythromycin and tylosin, respectively, were the precursor ions for collision-induced-dissociation and two diagnostic product ions for each macrolide were identified for the unambiguous confirmation by selected reaction monitoring LC-MS-MS. Precision values (relative standard deviations) were all below 14.9%, whereas the overall accuracy (relative error) ranged from -17.7 to -9.8% for tylosin, from -17.5 to -10.7% for tilmicosin and from -19.6 to -13.7% for erythromycin, in all the investigated bovine tissues. The limits of quantification were 30 (muscle) or 40 (liver, kidney) microg kg(-1), 20 (muscle) or 150 (liver, kidney) microg kg(-1), 50 (muscle, liver) or 80 (kidney) microg kg(-1), 20 (muscle, liver) or 50 (kidney) microg kg(-1) for tylosin, tilmicosin, erytromycin and roxithromycin, respectively.     

Assay of Erythromycin from Human Serum by High Performance Liquid Chromatography with Electrochemical Detection

Abstract

A sensitive and selective method has been developed for the determination of serum concentrations of erythromycin A by high performance liquid chromatography with electrochemical detection. Erythromycin was extracted from alkalinized serum samples with methyl t-butyl ether. After evaporation of the ether, the samples were reconstituted in acetonitrile/ammonium acetate and washed with hexane. Aliquots were injected onto a Sepralyte diphenyl column. The mobile phase consists of acetonitrile/sodium perchlorate/ammonium acetate/methanol under isocratic conditions. Eluted peaks were detected by dual coulometric electrodes operated in the oxidative screen mode. The recovery of erythromycin from serum was 84%. Assay limit of quantification was 0.05 μg/ml serum, and dynamic linear range was 0.05–1.5 μg/ml. This method was used to quantitate both erythromycin and its gastric degradation products from human serum. Additionally, other macrolide antibiotics could be quantified by electrochemical detection. Analytical results for erythromycin compared favorably with those obtained with a standard microbiological assay.     

High performance thin layer chromatographic determination of erythromycin in pharmaceutical preparations

Summary A high performance thin layer chromatographic method was developed for the determination of erythromycin. The drug was separated on a silica gel 60 plate and developed in methanol by means of an automatic multiple development. The chromatogram was sprayed with 10% sulphuric acid solution and heated at 100°C for 10–15 minutes. The area of the spot was quantified by a TLC scanner at a wavelength of 410 nm. A linear calibration curve was established over the range of 4–6 μg in 10μl of erythromycin. The relative standard deviation for five replicate determinations was found to be 1.45% for 5 μg in 10 μl of erythromycin standard. The average percentage recovery was found to be 99.87. The method has been applied to the determination of erythromycin in various pharmaceutical dosage forms. Common excipients in formulations do not interfere. After optimizing the solvent system, it was found that the use of silica gel 60 F₂₅₄ TLC plate with a DVS composed of ethyl acetate, ethanol and 10% sodium acetate pH 9.5 (9:7:8) led to the differentiation and quantitation of erythromycins A, B and C with an R.S.D. of less than 2.0%. The method is simple, precise and inexpensive. It should be used for routine analysis.     

Analysis of erythromycin in biological fluids by high-performance liquid chromatography with electrochemical detection

A simple and sensitive high-performance liquid chromatographic assay was developed for the quantitative determination of major erythromycin components and their potential metabolites or degradation products in plasma and urine. An ether extract of alkalized plasma sample was chromatographed on a reversed-phase column and the components in the column effluent were monitored by an electrochemical detector. The recovery of the drug from extraction was virtually 100%. The detection limits for erythromycin A in plasma were 5-10 ng/ml and 30 ng/ml using 1 and 0.2 ml of sample, respectively. For urine samples, a simple one-step deproteinization with two volumes of acetonitrile was satisfactory for analysis. The method has been evaluated in plasma and urine from dogs receiving oral or intravenous erythromycin A. The standard curves for potential metabolites or degradation products were not constructed due to the lack of sufficient samples.